0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
China Anti-Peptic Ulcer Drugs Market Report & Forecast 2021-2027
Published Date: October 2021
|
Report Code: QYRE-Auto-3301
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
China Anti Peptic Ulcer Drugs Market Report Forecast 2021 2027

China Anti-Peptic Ulcer Drugs Market Report & Forecast 2021-2027

Code: QYRE-Auto-3301
Report
October 2021
90 Pages
QYResearch
Region: Global, China,
Description
Table of Content
Tables & Figures
China Anti-Peptic Ulcer Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions)
China Anti-Peptic Ulcer Drugs Market Segment Percentages, By Type, 2020 (%)
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Ulcer Protective Drugs
China Anti-Peptic Ulcer Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions)
China Anti-Peptic Ulcer Drugs Market Segment Percentages, By Application, 2020 (%)
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Peptic Ulcer Drugs revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Anti-Peptic Ulcer Drugs revenues share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

AstraZeneca
Ask-pharm
Takeda
Yangtze River Pharm
Shandong Luoxin
Huadong Medicine
Changzhou Siyao
Beijing Yuekang
Guangdong Dahua
Xian Janssen
1 Introduction to Research & Analysis Reports
1.1 Anti-Peptic Ulcer Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Anti-Peptic Ulcer Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Anti-Peptic Ulcer Drugs Overall Market Size
2.1 China Anti-Peptic Ulcer Drugs Market Size: 2021 VS 2027
2.2 China Anti-Peptic Ulcer Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-Peptic Ulcer Drugs Players in China Market
3.2 Top China Anti-Peptic Ulcer Drugs Companies Ranked by Revenue
3.3 China Anti-Peptic Ulcer Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anti-Peptic Ulcer Drugs Companies in China Market, by Revenue in 2020
3.5 Companies Anti-Peptic Ulcer Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-Peptic Ulcer Drugs Players in China Market
3.6.1 List of Tier 1 Anti-Peptic Ulcer Drugs Companies in China
3.6.2 List of Tier 2 and Tier 3 Anti-Peptic Ulcer Drugs Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Anti-Peptic Ulcer Drugs Market Size Markets, 2021 & 2027
4.1.2 Proton Pump Inhibitors (PPIs)
4.1.3 Potassium-Competitive Acid Blockers (P-CAB)
4.1.4 Antacids
4.1.5 H2 Antagonists
4.1.6 Ulcer Protective Drugs
4.2 By Type - China Anti-Peptic Ulcer Drugs Revenue & Forecasts
4.2.1 By Type - China Anti-Peptic Ulcer Drugs Revenue, 2016-2021
4.2.2 By Type - China Anti-Peptic Ulcer Drugs Revenue, 2022-2027
4.2.3 By Type - China Anti-Peptic Ulcer Drugs Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Anti-Peptic Ulcer Drugs Market Size, 2021 & 2027
5.1.2 Gastritis
5.1.3 Gastric Ulcers
5.1.4 Duodenal Ulcers
5.1.5 Gastroesophageal Reflux Disease (GERD)
5.2 By Application - China Anti-Peptic Ulcer Drugs Revenue & Forecasts
5.2.1 By Application - China Anti-Peptic Ulcer Drugs Revenue, 2016-2021
5.2.2 By Application - China Anti-Peptic Ulcer Drugs Revenue, 2022-2027
5.2.3 By Application - China Anti-Peptic Ulcer Drugs Revenue Market Share, 2016-2027
6 Anti-Peptic Ulcer Drugs Companies Profiles
6.1 AstraZeneca
6.1.1 AstraZeneca Company Details
6.1.2 AstraZeneca Business Overview
6.1.3 AstraZeneca Anti-Peptic Ulcer Drugs Introduction
6.1.4 AstraZeneca Anti-Peptic Ulcer Drugs Revenue in China Market (2016-2021)
6.1.5 AstraZeneca Recent Developments
6.2 Ask-pharm
6.2.1 Ask-pharm Company Details
6.2.2 Ask-pharm Business Overview
6.2.3 Ask-pharm Anti-Peptic Ulcer Drugs Introduction
6.2.4 Ask-pharm Anti-Peptic Ulcer Drugs Revenue in China Market (2016-2021)
6.2.5 Ask-pharm Recent Developments
6.3 Takeda
6.3.1 Takeda Company Details
6.3.2 Takeda Business Overview
6.3.3 Takeda Anti-Peptic Ulcer Drugs Introduction
6.3.4 Takeda Anti-Peptic Ulcer Drugs Revenue in China Market (2016-2021)
6.3.5 Takeda Recent Developments
6.4 Yangtze River Pharm
6.4.1 Yangtze River Pharm Company Details
6.4.2 Yangtze River Pharm Business Overview
6.4.3 Yangtze River Pharm Anti-Peptic Ulcer Drugs Introduction
6.4.4 Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue in China Market (2016-2021)
6.4.5 Yangtze River Pharm Recent Developments
6.5 Shandong Luoxin
6.5.1 Shandong Luoxin Company Details
6.5.2 Shandong Luoxin Business Overview
6.5.3 Shandong Luoxin Anti-Peptic Ulcer Drugs Introduction
6.5.4 Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue in China Market (2016-2021)
6.5.5 Shandong Luoxin Recent Developments
6.6 Huadong Medicine
6.6.1 Huadong Medicine Company Details
6.6.2 Huadong Medicine Business Overview
6.6.3 Huadong Medicine Anti-Peptic Ulcer Drugs Introduction
6.6.4 Huadong Medicine Anti-Peptic Ulcer Drugs Revenue in China Market (2016-2021)
6.6.5 Huadong Medicine Recent Developments
6.7 Changzhou Siyao
6.7.1 Changzhou Siyao Company Details
6.7.2 Changzhou Siyao Business Overview
6.7.3 Changzhou Siyao Anti-Peptic Ulcer Drugs Introduction
6.7.4 Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue in China Market (2016-2021)
6.7.5 Changzhou Siyao Recent Developments
6.8 Beijing Yuekang
6.8.1 Beijing Yuekang Company Details
6.8.2 Beijing Yuekang Business Overview
6.8.3 Beijing Yuekang Anti-Peptic Ulcer Drugs Introduction
6.8.4 Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue in China Market (2016-2021)
6.8.5 Beijing Yuekang Recent Developments
6.9 Guangdong Dahua
6.9.1 Guangdong Dahua Company Details
6.9.2 Guangdong Dahua Business Overview
6.9.3 Guangdong Dahua Anti-Peptic Ulcer Drugs Introduction
6.9.4 Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue in China Market (2016-2021)
6.9.5 Guangdong Dahua Recent Developments
6.10 Xian Janssen
6.10.1 Xian Janssen Company Details
6.10.2 Xian Janssen Business Overview
6.10.3 Xian Janssen Anti-Peptic Ulcer Drugs Introduction
6.10.4 Xian Janssen Anti-Peptic Ulcer Drugs Revenue in China Market (2016-2021)
6.10.5 Xian Janssen Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
    Table 1. Anti-Peptic Ulcer Drugs Market Opportunities & Trends in China Market
    Table 2. Anti-Peptic Ulcer Drugs Market Drivers in China Market
    Table 3. Anti-Peptic Ulcer Drugs Market Restraints in China Market
    Table 4. Key Players of Anti-Peptic Ulcer Drugs in China Market
    Table 5. Top Anti-Peptic Ulcer Drugs Players in China Market, Ranking by Revenue (2019)
    Table 6. China Anti-Peptic Ulcer Drugs Revenue by Companies, (US$, Mn), 2016-2021
    Table 7. China Anti-Peptic Ulcer Drugs Revenue Share by Companies, 2016-2021
    Table 8. Companies Anti-Peptic Ulcer Drugs Product Type
    Table 9. List of Tier 1 Anti-Peptic Ulcer Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Tier 2 and Tier 3 Anti-Peptic Ulcer Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – China Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2021 & 2027
    Table 12. By Type - China Anti-Peptic Ulcer Drugs Revenue (US$, Mn), 2016-2021
    Table 13. By Type - China Anti-Peptic Ulcer Drugs Revenue (US$, Mn), 2022-2027
    Table 14. By Application – China Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2021 VS 2027
    Table 15. By Application - China Anti-Peptic Ulcer Drugs Revenue (US$, Mn), 2016-2021
    Table 16. By Application - China Anti-Peptic Ulcer Drugs Revenue (US$, Mn), 2022-2027
    Table 17. AstraZeneca Company Details
    Table 18. AstraZeneca Business Overview
    Table 19. AstraZeneca Anti-Peptic Ulcer Drugs Product
    Table 20. AstraZeneca Anti-Peptic Ulcer Drugs Revenue in China Market (2016-2021) & (US$ Million)
    Table 21. AstraZeneca Recent Developments
    Table 22. Ask-pharm Company Details
    Table 23. Ask-pharm Business Overview
    Table 24. Ask-pharm Anti-Peptic Ulcer Drugs Product
    Table 25. Ask-pharm Anti-Peptic Ulcer Drugs Revenue in China Market (2016-2021) & (US$ Million)
    Table 26. Ask-pharm Recent Developments
    Table 27. Takeda Company Details
    Table 28. Takeda Business Overview
    Table 29. Takeda Anti-Peptic Ulcer Drugs Product
    Table 30. Takeda Anti-Peptic Ulcer Drugs Revenue in China Market (2016-2021) & (US$ Million)
    Table 31. Takeda Recent Developments
    Table 32. Yangtze River Pharm Company Details
    Table 33. Yangtze River Pharm Business Overview
    Table 34. Yangtze River Pharm Anti-Peptic Ulcer Drugs Product
    Table 35. Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue in China Market (2016-2021) & (US$ Million)
    Table 36. Yangtze River Pharm Recent Developments
    Table 37. Shandong Luoxin Company Details
    Table 38. Shandong Luoxin Business Overview
    Table 39. Shandong Luoxin Anti-Peptic Ulcer Drugs Product
    Table 40. Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue in China Market (2016-2021) & (US$ Million)
    Table 41. Shandong Luoxin Recent Developments
    Table 42. Huadong Medicine Company Details
    Table 43. Huadong Medicine Business Overview
    Table 44. Huadong Medicine Anti-Peptic Ulcer Drugs Product
    Table 45. Huadong Medicine Anti-Peptic Ulcer Drugs Revenue in China Market (2016-2021) & (US$ Million)
    Table 46. Huadong Medicine Recent Developments
    Table 47. Changzhou Siyao Company Details
    Table 48. Changzhou Siyao Business Overview
    Table 49. Changzhou Siyao Anti-Peptic Ulcer Drugs Product
    Table 50. Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue in China Market (2016-2021) & (US$ Million)
    Table 51. Changzhou Siyao Recent Developments
    Table 52. Beijing Yuekang Company Details
    Table 53. Beijing Yuekang Business Overview
    Table 54. Beijing Yuekang Anti-Peptic Ulcer Drugs Product
    Table 55. Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue in China Market (2016-2021) & (US$ Million)
    Table 56. Beijing Yuekang Recent Developments
    Table 57. Guangdong Dahua Company Details
    Table 58. Guangdong Dahua Business Overview
    Table 59. Guangdong Dahua Anti-Peptic Ulcer Drugs Product
    Table 60. Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue in China Market (2016-2021) & (US$ Million)
    Table 61. Guangdong Dahua Recent Developments
    Table 62. Xian Janssen Company Details
    Table 63. Xian Janssen Business Overview
    Table 64. Xian Janssen Anti-Peptic Ulcer Drugs Product
    Table 65. Xian Janssen Anti-Peptic Ulcer Drugs Revenue in China Market (2016-2021) & (US$ Million)
    Table 66. Xian Janssen Recent Developments
List of Figures
    Figure 1. Anti-Peptic Ulcer Drugs Segment by Type
    Figure 2. Anti-Peptic Ulcer Drugs Segment by Application
    Figure 3. China Anti-Peptic Ulcer Drugs Market Overview: 2020
    Figure 4. China Anti-Peptic Ulcer Drugs Market Size: 2021 VS 2027 (US$, Mn)
    Figure 5. China Anti-Peptic Ulcer Drugs Revenue, 2016-2027 (US$, Mn)
    Figure 6. The Top 3 and 5 Players Market Share by Anti-Peptic Ulcer Drugs Revenue in 2020
    Figure 7. By Type - China Anti-Peptic Ulcer Drugs Revenue Market Share, 2016-2027
    Figure 8. By Application - China Anti-Peptic Ulcer Drugs Revenue Market Share, 2016-2027
    Figure 9. AstraZeneca Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 10. Ask-pharm Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 11. Takeda Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 12. Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 13. Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 14. Huadong Medicine Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 15. Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 16. Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 17. Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 18. Xian Janssen Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3400
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5100
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$6800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String

RELATED REPORTS

Global and Japan qPCR Kits Market Insights Forecast to 2027
Global and Japan qPCR Kits Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-39Y7542
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and China Human ELISA Kits Market Insights Forecast to 2027
Global and China Human ELISA Kits Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-24Z7484
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and United States PCR Amplifier Market Insights Forecast to 2027
Global and United States PCR Amplifier Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-6W7895
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and China Porcine ELISA Kits Market Insights Forecast to 2027
Global and China Porcine ELISA Kits Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-37N7620
Wed Nov 24 00:00:00 UTC 2021

Add to Cart